AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Coralogix raises $115 million Series E at over $1 billion valuation
2
“We made another investment the morning after the war with Iran began”
3
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
4
Fintech unicorn Tipalti acquires Statement for $35-45M to expand real-time cash flow management
5
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
More news

pharmaceutical

4 stories about pharmaceutical
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million

06.03.19|Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
מנכ"ל איליי לילי ישראל דודו גל מנכ"לית פארמה ישראל עידית צ'רנוביץ ומנכ"ל abbvie ישראל רפי בלום

Regulation Hinders Innovative Drug Development in Israel, Executives Say

04.09.17|Naomi Zoreff
Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
עמיר לונדון מנכ"ל קמהדע

Developer Of Anti-Rabies Drug Jumps on FDA Approval

27.08.17|Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
Cummings Welch

U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices

21.08.17|Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies